compliance with our managed formulary, and there is always a route to obtain a non formulary drug if there is adequate justification from the physician. The low rate of nonformulary drug use indicates that formularies can work.
The best formularies are based on a therapeutically sound approach to choosing drugs with proven track records. Considerations include improvements in quality of life, decreases in hospitaliza-tion, replacements for surgery, or cures that were previously unknown. A 
_ Conclusion
Like many other aspects of managed care, the pharmacy benefit is changing as circumstances change for employers, plans, clinicians, and members. As Internet technology and the electronic medical edit advance, formulary administration becomes simpler. As plans merge and members move from one MCO to another, member or clinician concern about perceived or real restrictions change. If the MCO does not act on these concerns, they may migrate to members elected representatives. This will eventually result in increased oversight.
Pharmacists who practice in MCOs must understand the importance of responsible formulary development and implementation. Whenever possible, legitimate concerns must be addressed quickly When misperception emerges, we have a responsibility to communicate factual information effectively Our unique role as the drug expert and health educator is essential in the entire formulary process. Clearly, the debate about managed care formularies will continue. The intensity of the debate will only be tempered by our ability to find reasonable middle ground. .
